[(1S,4R,7S,9R,13R)-16-Hydroxy-11-(hydroxymethyl)-4,8,8,15-tetramethyl-12-oxo-3-oxatetracyclo[11.3.0.02,4.07,9]hexadec-10-en-13-yl] 3 -phenylprop-2-enoate
CAS: 62820-11-5
Ref. 3D-MCA82011
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Product Information
- 2-Propenoic acid, 3-phenyl-, (1aS,1bR,2S,3S,4aR,6E,7aR,8aS,10aR)-1a,1b,2,3,4,5,7a,8,8a,9,10,10a-dodecahydro-2-hydroxy-6-(hydroxymethyl)-3,8,8,10a-tetramethyl-5-oxo-4aH-cyclopenta[3,4]cyclopropa[8,9]cycloundec[1,2-b]oxiren-4a-yl ester, (2E)-
- 2-Propenoic acid, 3-phenyl-, 1a,1b,2,3,4,5,7a,8,8a,9,10,10a-dodecahydro-2-hydroxy-6-(hydroxymethyl)-3,8,8,10a-tetramethyl-5-oxo-4aH-cyclopenta[3,4]cyclopropa[8,9]cycloundec[1,2-b]oxiren-4a-yl ester, [1aS-[1aR*,1bS*,2R*,3R*,4aS*(E),6E,7aS*,8aR*,10aS*]]-
- Jolkinol A
- 4aH-Cyclopenta[3,4]cyclopropa[8,9]cycloundec[1,2-b]oxirene, 2-propenoic acid deriv.
(1S,4R,7S,9R,13R)-16-Hydroxy-11-(hydroxymethyl)-4,8,8,15-tetramethyl-12-oxo-3-oxatetracyclo[11.3.0.02,4.07,9]hexadec-10-en-13-yl] 3 -phenylprop-2-enoate is a skeleton that contains a mixture of daphnine and lathyris diterpenes. It has been shown to have antitumour activity in both rodent models and in human cancer cells. The biological properties of this compound are being investigated further. This compound is known to be an inhibitor of translation and transcription by binding to the ribosome and inhibiting protein synthesis at the translational level. [(1S,4R,7S,9R,13R)-16-Hydroxy-11-(hydroxymethyl
Chemical properties
Technical inquiry about: 3D-MCA82011 [(1S,4R,7S,9R,13R)-16-Hydroxy-11-(hydroxymethyl)-4,8,8,15-tetramethyl-12-oxo-3-oxatetracyclo[11.3.0.02,4.07,9]hexadec-10-en-13-yl] 3 -phenylprop-2-enoate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
